FILE PHOTO: A medical worker administers a dose of the "Comirnaty" Pfizer-BioNTech COVID-19 vaccine in a vaccination center in Paris as part of the coronavirus disease (COVID-19) vaccination campaign in France, May 12, 2021. REUTERS/Gonzalo Fuentes/File Photo
NEW DELHI/NEW YORK (Reuters) -Pfizer and the Indian government are seeking to resolve tensions over a demand by the U.S. drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries where its shots have already been widely used, including Britain and the United States.
